Diminished benefits of drug-eluting stents versus bare metal stents in patients with severe renal insufficiency

Nephron - Clinical Practice

Volumn 113, Issue 3, 2009, Pages

  Rosenblum, Michael A ^a   Robbins, Michael J ^c   Farkouh, Michael E ^c   Winston, Jonathan A ^b   Kim, Michael C ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Department of Internal Medicine

^c MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Drug eluting stents; End stage renal disease; Target lesion revascularization

Indexed keywords

CREATININE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BARE METAL STENT; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; HUMAN; HYPERLIPIDEMIA; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CORONARY RESTENOSIS; DATABASES, FACTUAL; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; METALS; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STENTS; TREATMENT OUTCOME;

EID: 68349109552     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000232602     Document Type: Article

References (22)

1. Ahmed WH, Shubrooks SJ, Gibson CM, Baim DS, Bittl JA: Complications and longterm outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. Am Heart J 1994; 128: 252-255.
2. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartzler GO: Short-and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990; 119: 484-489.
3. Gruberg L, Weissman NJ, Waksman R, et al: Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency. Am J Cardiol 2002; 89: 54-57.
4. Best PJ, Lennon R, Ting HH, et al: The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002; 39: 1113-1119.
5. Azar RR, Prpic R, Ho KK, et al: Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 2000; 86: 485-489.
6. Cohen DJ, Bakhai A, Shi C, et al: Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: Results from the sirolimus-eluting balloon expandable stent in the treatment of patients with de novo native coronary artery lesions (SIRIUS) trial. Circulation 2004; 110: 508-514.
7. Ong AT, van Domburg RT, Aoki J, Sonnenschein K, Lemos PA, Serruys PW: Sirolimuseluting stents remain superior to bare-metal stents at two years: Medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol 2006; 47: 1356-1360.
8. Roiron C, Sanchez P, Bouzamondo A, Lechat P, Montalescot G: Drug-eluting stents: An updated meta-analysis of randomised controlled trials. Heart. 2006; 92: 641-649.
9. Stone GW, Ellis SG, Cox DA, et al: A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231.
10. Foley RN, Murray AM, Li S, et al: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998-1999. J Am Soc Nephrol 2005; 16: 489-495.
11. Hassani SE, Chu WW, Wolfram RM, et al: Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J Invasive Cardiol 2006; 18: 273-277.
12. Zhang RY, Ni JW, Zhang JS, et al: Long-term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention. Chin Med J (Engl) 2006; 119: 1176-1181.
13. Rubenstein MH, Harrell LC, Sheynberg BV, Schunkert H, Bazari H, Palacios IF: Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 2000; 102: 2966-2972.
14. Moses JW, Leon MB, Popma JJ, et al: Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
15. Halkin A, Mehran R, Casey CW, et al: Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: Results from the TAXUS-IV trial. Am Heart J 2005; 150: 1163-1170.
16. Kuchulakanti PK, Torguson R, Chu WW, et al: Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol 2006; 97: 792-797. (Pubitemid 43313248)
17. Ardissino D, Cavallini C, Bramucci E, et al: Sirolimus-eluting vs. uncoated stents for prevention of restenosis in small coronary arteries: A randomized trial. JAMA 2004; 292: 2727.
18. Apostoloviæ S, Perisiæ Z, Tomaseviæ M, Stankovic G, Pavloviæ M, Salinger-Martinoviæ S. Late thrombosis of coronary bare-metal stent-case report. Srp Arh Celok Lek 2006; 134: 155-158.
19. Chrissoheris MP, Mruthyunjayanna V, Donohue TJ: Late thrombosis of drug-eluting stents after discontinuation of clopidogrel: Report of two cases and review of the literature. Conn Med 2006; 70: 485-490.
20. Park DW, Park SW, Park KH, et al: Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 2006; 98: 352-356.
21. Serruys PW, Kukreja N: Late stent thrombosis in drug-eluting stents: Return of the 'VB syndrome'. Nat Clin Pract Cardiovasc Med 2006; 3: 637.
22. Wernick MH, Jeremias A, Carrozza JP: Drug-eluting stents and stent thrombosis: A cause for concern? Coron Artery Dis 2006; 17: 661-665.